IVI Fertility Launches New Partnership with Ferring
World leading fertility group IVI Fertility have announced the launch of a new fellowship programme, IVI-FER, made possible by an unrestricted educational grant from Ferring Pharmaceuticals and the IVI Foundation.
IVI-FER is a tailored, accredited clinical training programme open to young clinicians across Europe specialising in Obstetrics and Gynaecology. The programme is supported by the European Board & College of Obstetrics and Gynaecology (EBCOG), the European Society of Human Reproduction and Embryology (ESHRE), the University of Valencia, and the Spanish Fertility Society (SEF).
The IVI-FER fellowship will offer the successful applicant access to expert tutors, opportunities to follow personalised educational targets, hands-on clinical experience, and attendance to educational meetings, including at least one ESHRE meeting.
Speaking about the launch of the IVI-FER fellowship, Programme Director, Professor Antonio Pellicer commented:
“At IVI, we pride ourselves on our commitment to excellence in teaching and research. With support from Ferring Pharmaceuticals and the IVI Foundation, we are delighted to be able to offer this new training programme. It is a great example of how collaboration can help drive educational advancement in reproductive medicine.”
2016 will be the first year that the IVI-FER fellowship will be offered. Applications for the position will be open until 31 August, with the final decision to be announced by the end of October 2016.
For more details regarding entry criteria, programme offerings, timelines, and the application process, please visit http://www.ivi.net/Docs/Fellowship-IVIFER.pdf